Safety, Tolerability and Pharmacokinetic‑Pharmacodynamic Relationship of NX210c Peptide in Healthy Elderly Volunteers: Randomized, Placebo‑Controlled, Double‑Blind, Multiple Ascending Dose Study

ORIGINAL RESEARCH article Neurology and Therapy 2024 Annette Janus 1 · Daniel Dumas 2,3 · Juliette Le Douce 1 · Sébastien Marie 1 · Giuseppe Pasculli 4 · Pauline Bambury 4 · Sighild Lemarchant 1 · Philip Kremer 2,3 · Yann Godfrin 1,5 Axoltis Pharma, 60 Avenue Rockefeller, 69008 Lyon, France. Centre for Human Drug Research (CHDR), Leiden, The Netherlands Leiden University Medical Centre (LUMC), Leiden, The Netherlands InSilicoTrials Technologies, Trieste, Italy Godfrin Life‐Sciences, 8 Impasse de la Source, 69300 Caluire‐et‐Cuire, France PDF version

The release as fetched from its publisher. axoltis.com ↗